Graphene Varactor Sensors with Non-Covalent Surface Modification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting diseases through volatile organic compounds (VOCs) lack sensitivity and specificity, particularly at parts-per-billion (ppb) or parts-per-million (ppm) levels, and require improvements in non-covalent surface modifications for graphene-based sensors to effectively identify disease states.
Innovation Solution
The development of graphene varactors with non-covalent surface modification using π-electron-rich molecules such as pyrene derivatives and cyclodextrins, which form self-assembled monolayers providing high surface coverage and sensitivity for VOC detection, enabling the identification of disease states by analyzing binding patterns.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection methods are used for VOCs, then the detection process is simple, but the sensitivity and specificity are insufficient at ppb/ppm levels
Solution Approach 1:
The patent employs composite material structures combining graphene with various functional materials (metal oxides, carbon materials, polymers, liquids, gases) to create sensor elements that achieve high sensitivity and specificity for VOC detection at ppb/ppm levels while maintaining manageable device complexity through systematic material combination strategies
2Measurement precision
If non-covalent surface modification is applied to graphene, then the sensitivity for VOC detection is improved, but the manufacturing precision requirements increase
Solution Approach 1:
The patent utilizes parameter changes by controlling the surface modification process through adjustable parameters such as exposure time, concentration of modifying agents, temperature, and pressure conditions. This allows optimization of the non-covalent surface modification to achieve high VOC detection sensitivity while maintaining manufacturability through systematic parameter control rather than requiring ultra-precise manufacturing tolerances
3Reliability
If graphene-based varactors are used for disease detection, then the potential for early detection is high, but the reliability of disease state identification needs improvement
Solution Approach 1:
The patent applies segmentation by developing sensor arrays with multiple distinct sensing regions, each functionalized with different material combinations tailored for detecting specific VOC markers associated with different disease states. This segmented approach enables parallel detection of multiple disease indicators simultaneously, improving reliability of disease state identification while managing complexity through modular array design
Solution Approach 2:
The patent incorporates feedback mechanisms through reference sensor elements and control regions within the sensor array that provide baseline data for comparing VOC detections. This feedback system allows continuous calibration and validation of disease state identifications, enhancing reliability by enabling real-time verification of sensor responses against established reference standards
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The graphene varactors exhibit high sensitivity and specificity for VOC detection at ppb/ppm levels, allowing for the early identification of diseases such as cancer, cardiac diseases, and neurological disorders, with the non-covalent surface modification maintaining the stability and sensitivity of the graphene structure.
Implementation Method 1
The non-covalent functionalization of graphene with a self-assembled monolayer does not significantly affect the atomic structure of graphene, and provides a stable graphene-based sensor with high sensitivity towards a number of volatile organic compounds (VOCs) in the parts-per-billion (ppb) or parts-per-million (ppm) levels
Implementation Method 2
The non-covalent surface modification of graphene with π-electron-rich molecules such as pyrene derivatives and cyclodextrins, which form self-assembled monolayers
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
A medical device which can include a graphene varactor (100). The graphene varactor (100) can include a graphene layer (108a, 108b) and a self-assembled monolayer disposed on an outer surface of the graphene layer through pi-pi stacking interactions. The self- assembled monolayer can provide a Langmuir theta value of at least 0.9. The self-assembled monolayer can include polycyclic aromatic hydrocarbons, tetraphenylporphyrins or derivatives thereof, metallotetraphenylporphyrins, or aromatic cyclodextrins. Corresponding fabrication method and a method of detecting an analyte in a gaseous sample of a patient with the medical device are also disclosed.